The evaluation of malnutrition in cancer patients who treated with concurrent chemoradiotherapy at Ubonratchathani cancer hospital

Main Article Content

Manit Saeteaw
Thanut Khuayjarernpanishk
Ramida Mutthapha
Sovipa Polyiam

Abstract

Concurrent chemoradiotherapy (CCRT) is a main treatment strategy that has been recommended for the management of several types of cancer. Malnutrition is one of the most undesirable complication during CCRT. Objective: The purpose of this study was to evaluate the incidence of malnutrition in cancer patients undergoing CCRT at Ubonratchathani Cancer Hospital. Methods: The retrospective cohort study was conducted in cancer patients. All patient medical records who were treated with CCRT during June and December 2013 were reviewed. Malnutrition incidences were analyzed using descriptive analysis. Hematologic parameters for categorized malnutrition group were compared using Mann-Whitney U test. Correlations between decreasing body weight percentages during CCRT and each differences in hematologic parameters percentages were analyzed using linear regression statistic. Results: Medical records of 201 cancer patients were reviewed. Incidence of malnutrition defined by body mass index less than 18.5 kg/m2 was 22.9%.  Incidence of malnutrition defined by body weight loss at least 10% from baseline was 22.9%. Patients who loss body weight at least 10% from baseline has significant declined hematologic laboratory parameters more than patients who loss body weight at less than 10% group (P < 0.05). Correlation between body weight losing percentages during CCRT and both declined hemoglobin percentages (Beta = 0.254, P = 0.003) and white blood cell count percentages (Beta = 0.224, P = 0.009) were found in this study. Conclusion: Malnutrition is a common problem during CCRT. Weight loss during cancer treatment correlate with declined hematologic laboratory parameters.

Article Details

Section
Pharmaceutical Practice

References

Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, et al. Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr. 2015;34(3):335-40.

Chang PH, Yeh KY, Huang JS, Lai CH, Wu TH, Lan YJ, et al. Pretreatment performance status and nutrition are associated with early mortality of locallyadvanced head and neck cancer patients undergoing concurrent chemoradiation. Eur Arch Otorhinolaryngol. 2013;270:1909-15.

Dechaphunkul T, Pruegsanusak K, Sangthawan D, Sunpaweravong P. Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma. Head Neck Oncol 2011;3:30.

Fu ZZ, Li K, Peng Y, Zheng Y, Cao LY, Zhang YJ, Sun YM. Efficacy and toxicity of different concurrent chemoradiotherapy regimens in the treatment of advanced cervical cancer: A network meta-analysis. Medicine (Baltimore). 2017;96(2):e5853.

Langius JA, Bakker S, Rietveld DH, Kruizenga HM, Langendijk JA, Weijs PJ, et al. Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer 2013;109:1093-1099.

Lin A, Jabbari S, Worden FP, Bradford CR, Chepeha DB, Teknos TN, et al. Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005;63:1413-8.

Morgan MA, Ten Haken RK, Lawrence TS.Essentials of radiation therapy. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, editors. Cancer: Principles & Practice of Oncology. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2015. P 137-155.

National Cancer Institute. Common Terminology Criteria for Adverse Events, Version 4.0 [internet]. 2009 [cited 9th January 2014]. Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf.

National cancer institute. Hospital-based cancer registry 2015 [internet]. 2017 [cited 26th December 2017]. Available from: http://www.nci.go.th/th/File_download/Nci%20Cancer%20Registry/HOSPITAL-BASED%202015.pdf

National comprehensive cancer network. NCCN clinical practice guidelines in oncology (NCCN guildlines®) [internet]. 2017 [cited 9th December 2017]. Available from: http://www.nccn.org

National Statistical Office. Number of deaths by leading cause of death and sex, whole kingdom : 2007-2014 [internet]. 2014 [cited 26th January 2015]. Available from: http://service.nso.go.th/nso/web/statseries/statseries09.html

Naumann P, Habermehl D, Welzel T, Debus J, Combs SE. Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer. Strahlenther Onkol 2013;189:745-752.

Paccagnella A, Morello M, Da Mosto MC, Baruffi C, Marcon ML, Gava A, et al. Early nutritional intervention improves treatment tolerance and outcomes in head and neckcancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer. 2010;18:837-45.

Platek ME, Myrick E, McCloskey SA, Gupta V, Reid ME, Wilding GE, et al. Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways. Support Care Cancer. 2013;21:2825-33.

Rosenberg SA. Principles of Surgical Oncology. In: DeVita VT Jr, Lawrence, TS, Rosenberg SA, editors. Cancer: Principles & Practice of Oncology. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. P.284-306.

Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 2004;90:1905-11.

Seiwert TY, Salama JK, Vokes EE. The concurrent chemoradiation paradigm--general principles. Nat Clin Pract Oncol. 2007;4:86-100.

Shen LJ, Chen C, Li BF, Gao J, Xia YF. High Weight Loss during Radiation Treatment Changes the Prognosis in Under-/Normal Weight Nasopharyngeal Carcinoma Patients for the Worse: A Retrospective Analysis of 2433 Cases. PLoS One 2013;8.e68660.

White JV, Guenter P, et al. Consensus Statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: Characteristics Recommended for the Identification and Documentation of Adult Malnutrition (Under-nutrition). JPEN J Parent Ent Nutr. 2012; 36:275-283.

Yuenyao P, Chumworathayi B, Luanratanakorn S, Wongsena M, Soopa-atakon P, Chotanaprasit T. Hematologic toxicities of cisplatin concurrent chemoradiation in cervical cancer at Ubonrajchathani Cancer Center. Srinagarind Medical Journal 2007;22:127-32.